Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-06

Clinical Trial Update: Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment [NA]

View source ↗

Summary

Göteborg University-sponsored clinical trial comparing mineralocorticoid receptor antagonists versus surgical treatment for unilateral primary hyperaldosteronis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)
  • eplerenone (eplerenone)

Snippet

Sponsor: Göteborg University | Conditions: Primary Hyperaldosteronism Due to Adrenal Adenoma | NA | Status: RECRUITING